1088PAnalysis of immune and genomic landscapes of patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with pembrolizumab in the INSPIRE study. (23rd October 2018) - Oliva Bernal, M; Lien, S; Wang, B X; Yang, S C; Spreafico, A; Jang, R; Elston, S; Jennings, S; Jiang, H; Haibe-Kains, B; Pugh, T; Ohashi, P; et al.